BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 38931297)

  • 1. D-Tagatose: A Rare Sugar with Functional Properties and Antimicrobial Potential against Oral Species.
    Ortiz AC; Fideles SOM; Reis CHB; Pagani BT; Bueno LMM; Moscatel MBM; Buchaim RL; Buchaim DV
    Nutrients; 2024 Jun; 16(12):. PubMed ID: 38931297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. D-Tagatose Effectively Reduces the Number of Streptococcus mutans and Oral Bacteria in Healthy Adult Subjects: A Chewing Gum Pilot Study and Randomized Clinical Trial.
    Nagamine Y; Hasibul K; Ogawa T; Tada A; Kamitori K; Hossain A; Yamaguchi F; Tokuda M; Kuwahara T; Miyake M
    Acta Med Okayama; 2020 Aug; 74(4):307-317. PubMed ID: 32843762
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Potential of Prebiotic D-Tagatose for Prevention of Oral Disease.
    Mayumi S; Kuboniwa M; Sakanaka A; Hashino E; Ishikawa A; Ijima Y; Amano A
    Front Cell Infect Microbiol; 2021; 11():767944. PubMed ID: 34804997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Antimicrobial Peptide GH12 on the Cariogenic Properties and Composition of a Cariogenic Multispecies Biofilm.
    Jiang W; Wang Y; Luo J; Li X; Zhou X; Li W; Zhang L
    Appl Environ Microbiol; 2018 Dec; 84(24):. PubMed ID: 30341079
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potent inhibitory effects of D-tagatose on the acid production and water-insoluble glucan synthesis of Streptococcus mutans GS5 in the presence of sucrose.
    Sawada D; Ogawa T; Miyake M; Hasui Y; Yamaguchi F; Izumori K; Tokuda M
    Acta Med Okayama; 2015; 69(2):105-11. PubMed ID: 25899632
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of Rubusoside, a Natural Sucrose Substitute, on Streptococcus mutans Biofilm Cariogenic Potential and Virulence Gene Expression
    Guan C; Che F; Zhou H; Li Y; Li Y; Chu J
    Appl Environ Microbiol; 2020 Aug; 86(16):. PubMed ID: 32503907
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effect of zingiber officinale towards Streptococcus mutans virulence and caries development: in vitro and in vivo studies.
    Hasan S; Danishuddin M; Khan AU
    BMC Microbiol; 2015 Jan; 15(1):1. PubMed ID: 25591663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Targeting of Streptococcus mutans Biofilms by a Novel Small Molecule Prevents Dental Caries and Preserves the Oral Microbiome.
    Garcia SS; Blackledge MS; Michalek S; Su L; Ptacek T; Eipers P; Morrow C; Lefkowitz EJ; Melander C; Wu H
    J Dent Res; 2017 Jul; 96(7):807-814. PubMed ID: 28571487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. D‑Tagatose inhibits the growth and biofilm formation of Streptococcus mutans.
    Hasibul K; Nakayama-Imaohji H; Hashimoto M; Yamasaki H; Ogawa T; Waki J; Tada A; Yoneda S; Tokuda M; Miyake M; Kuwahara T
    Mol Med Rep; 2018 Jan; 17(1):843-851. PubMed ID: 29115611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sustainable inhibition efficacy of liposome-encapsulated nisin on insoluble glucan-biofilm synthesis by Streptococcus mutans.
    Yamakami K; Tsumori H; Sakurai Y; Shimizu Y; Nagatoshi K; Sonomoto K
    Pharm Biol; 2013 Feb; 51(2):267-70. PubMed ID: 23116173
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Understanding the Basis of METH Mouth Using a Rodent Model of Methamphetamine Injection, Sugar Consumption, and Streptococcus mutans Infection.
    Lee HH; Sudhakara P; Desai S; Miranda K; Martinez LR
    mBio; 2021 Mar; 12(2):. PubMed ID: 33688011
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antibacterial and Antibiofilm Activities of a Novel Synthetic Cyclic Lipopeptide against Cariogenic Streptococcus mutans UA159.
    Min KR; Galvis A; Williams B; Rayala R; Cudic P; Ajdic D
    Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28533236
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The synthetic human beta-defensin-3 C15 peptide exhibits antimicrobial activity against Streptococcus mutans, both alone and in combination with dental disinfectants.
    Ahn KB; Kim AR; Kum KY; Yun CH; Han SH
    J Microbiol; 2017 Oct; 55(10):830-836. PubMed ID: 28956355
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted antimicrobial therapy against Streptococcus mutans establishes protective non-cariogenic oral biofilms and reduces subsequent infection.
    Li LN; Guo LH; Lux R; Eckert R; Yarbrough D; He J; Anderson M; Shi WY
    Int J Oral Sci; 2010 Jun; 2(2):66-73. PubMed ID: 20737932
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A tooth-binding antimicrobial peptide to prevent the formation of dental biofilm.
    Zhang LY; Fang ZH; Li QL; Cao CY
    J Mater Sci Mater Med; 2019 Mar; 30(4):45. PubMed ID: 30929087
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A comparative study of the effect of probiotics on cariogenic biofilm model for preventing dental caries.
    Lee SH; Kim YJ
    Arch Microbiol; 2014 Aug; 196(8):601-9. PubMed ID: 24919536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sugar substitutes, chewing gum and dental caries--a review.
    Edgar WM
    Br Dent J; 1998 Jan; 184(1):29-32. PubMed ID: 9479811
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of the antimicrobial decapeptide KSL on the growth of oral pathogens and Streptococcus mutans biofilm.
    Liu Y; Wang L; Zhou X; Hu S; Zhang S; Wu H
    Int J Antimicrob Agents; 2011 Jan; 37(1):33-8. PubMed ID: 20956070
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Utilization of the extract of Cedrus deodara (Roxb. ex D.Don) G. Don against the biofilm formation and the expression of virulence genes of cariogenic bacterium Streptococcus mutans.
    Zhang Z; Lyu X; Xu Q; Li C; Lu M; Gong T; Tang B; Wang L; Zeng W; Li Y
    J Ethnopharmacol; 2020 Jul; 257():112856. PubMed ID: 32278760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticariogenic activities of Libidibia ferrea, gallic acid and ethyl gallate against Streptococcus mutans in biofilm model.
    Passos MR; Almeida RS; Lima BO; Rodrigues JZS; Macêdo Neres NS; Pita LS; Marinho PDF; Santos IA; da Silva JP; Oliveira MC; Oliveira MA; Pessoa SMB; Silva MML; Silveira PHS; Reis MM; Santos IP; Ricardo LON; Andrade LOSB; Soares AB; Correia TML; Souza ÉP; Pires PN; Cruz MP; Marques LM; Uetanabaro APT; Yatsuda R
    J Ethnopharmacol; 2021 Jun; 274():114059. PubMed ID: 33794333
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.